These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7050931)

  • 1. Special feature: in quest of an effective antiemetic in cancer chemotherapy. Research with antiemetics for cancer chemotherapy: problems and possibilities.
    Maxwell MB
    Oncol Nurs Forum; 1982; 9(3):11-6. PubMed ID: 7050931
    [No Abstract]   [Full Text] [Related]  

  • 2. Problems in antiemetic trial design and interpretation.
    Krasnow SH
    Oncology (Williston Park); 1989 Aug; 3(8 Suppl):5-10. PubMed ID: 2701576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiemetic studies: a methodological discussion.
    Olver IN; Simon RM; Aisner J
    Cancer Treat Rep; 1986 May; 70(5):555-63. PubMed ID: 3708607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiemetic study design: a discussion of Dr Olver's paper.
    Groshen S
    Br J Cancer Suppl; 1992 Dec; 19():S35-7. PubMed ID: 1467199
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative trial between two drugs in the treatment of vomiting induced by anti-cancer chemotherapy (author's transl)].
    Zylberait D; Krulik M; Audebert AA; Debray J
    Sem Hop; 1981 Jan 8-15; 57(1-2):47-9. PubMed ID: 6258237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of antiemetic properties of clebopride and metoclopramide in vomiting produced by cis-platinum (author's transl)].
    Padrón F; Sanz J; Flórez J
    Med Clin (Barc); 1981 Sep; 77(4):167-70. PubMed ID: 7031384
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
    Herrstedt J
    Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiemetic therapy in patients treated with cisplatin chemotherapy.
    Roila F; Basurto C; Bracarda S; Del Favero A; Tonato M
    J Chemother; 1989 Jul; 1(4 Suppl):1281-5. PubMed ID: 16312866
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiemetic study design: desirable objectives, stratifications and analyses.
    Olver IN
    Br J Cancer Suppl; 1992 Dec; 19():S30-3; discussion S33-4. PubMed ID: 1467198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of success: parameters of efficacy.
    de Mulder PH
    Br J Cancer Suppl; 1992 Dec; 19():S68. PubMed ID: 1467205
    [No Abstract]   [Full Text] [Related]  

  • 11. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
    Drug Ther Bull; 1984 Feb; 22(3):9-11. PubMed ID: 6321126
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance and principles of antiemetic therapy in cytostatic treatment].
    Joss R; Buser K; Cerny T; Rohrbach D; Brunner KW
    Ther Umsch; 1988 Jun; 45(6):397-402. PubMed ID: 3046037
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of dexamethasone (Hexadrol) as an antiemetic in association with chemotherapy for neoplastic disease.
    Gathercole F; Connolly N; Birdsell J
    Oncol Nurs Forum; 1982; 9(3):17-9. PubMed ID: 6921787
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy-induced nausea and vomiting. Easing patients' fear and discomfort with effective antiemetic regimens.
    Bilgrami S; Fallon BG
    Postgrad Med; 1993 Oct; 94(5):55-8, 62-4. PubMed ID: 8415336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice.
    Hesketh PJ
    Oncologist; 1999; 4(3):191-6. PubMed ID: 10394587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carryover and the two-period crossover clinical trial.
    Willan AR; Pater JL
    Biometrics; 1986 Sep; 42(3):593-9. PubMed ID: 3567292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
    Jordan K; Sippel C; Schmoll HJ
    Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurses' perceptions of antiemetic effectiveness.
    Rhodes VA; McDaniel RW; Simms SG; Johnson M
    Oncol Nurs Forum; 1995 Sep; 22(8):1243-52. PubMed ID: 8532549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Andersson H; Hansen O; Sørensen BT; Räisänen I
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():31-6. PubMed ID: 7749168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.